{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T13:45:39Z","timestamp":1758462339598,"version":"3.44.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,21]]},"DOI":"10.7759\/cureus.92819","type":"journal-article","created":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:49:49Z","timestamp":1758440989000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Impact of Retroperitoneal Lymphadenectomy in Terms of Morbidity and Survival in Advanced Epithelial Ovarian Cancer"],"prefix":"10.7759","author":[{"given":"Mukurdipi","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bittu","family":"Bhukkal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v11.i11.868","article-title":"Liquid biopsy in ovarian cancer: catching the silent killer before it strikes","volume":"11","author":"Feeney L","year":"2020","unstructured":"Feeney L, Harley IJ, McCluggage WG, Mullan PB, Beirne JP. Liquid biopsy in ovarian cancer: catching the silent killer before it strikes. World J Clin Oncol. 2020, 11:868-89. 10.5306\/wjco.v11.i11.868","journal-title":"World J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082427","article-title":"Impact of lymphadenectomy on survival of patients with serous advanced ovarian cancer after neoadjuvant chemotherapy: a French national multicenter study (FRANCOGYN)","volume":"9","author":"Bund V","year":"2020","unstructured":"Bund V, Lecointre L, Velten M, et al.. Impact of lymphadenectomy on survival of patients with serous advanced ovarian cancer after neoadjuvant chemotherapy: a French national multicenter study (FRANCOGYN). J Clin Med. 2020, 9:2427. 10.3390\/jcm9082427","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001231","article-title":"Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial","volume":"30","author":"Koole S","year":"2020","unstructured":"Koole S, van Stein R, Sikorska K, et al.. Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial. Int J Gynecol Cancer. 2020, 30:888-92. 10.1136\/ijgc-2020-001231","journal-title":"Int J Gynecol Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.01.028","article-title":"Pelvic and aortic lymph node metastasis in epithelial ovarian cancer","volume":"105","author":"Pereira A","year":"2007","unstructured":"Pereira A, Magrina JF, Rey V, Cortes M, Magtibay PM. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Gynecol Oncol. 2007, 105:604-8. 10.1016\/j.ygyno.2007.01.028","journal-title":"Gynecol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.06.068","article-title":"Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer","volume":"195","author":"Aletti GD","year":"2006","unstructured":"Aletti GD, Dowdy S, Podratz KC, Cliby WA. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am J Obstet Gynecol. 2006, 195:1862-8. 10.1016\/j.ajog.2006.06.068","journal-title":"Am J Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603803","article-title":"The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients","volume":"96","author":"Chan JK","year":"2007","unstructured":"Chan JK, Urban R, Hu JM, et al.. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer. 2007, 96:1817-22. 10.1038\/sj.bjc.6603803","journal-title":"Br J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07144-1","article-title":"The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients","volume":"20","author":"Fang C","year":"2020","unstructured":"Fang C, Zhang Y, Zhao L, Chen X, Xia L, Zhang P. The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients. BMC Cancer. 2020, 20:654. 10.1186\/s12885-020-07144-1","journal-title":"BMC Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e67","article-title":"Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis","volume":"31","author":"Chiyoda T","year":"2020","unstructured":"Chiyoda T, Sakurai M, Satoh T, Nagase S, Mikami M, Katabuchi H, Aoki D. Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis. J Gynecol Oncol. 2020, 31:e67. 10.3802\/jgo.2020.31.e67","journal-title":"J Gynecol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13696","article-title":"Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: reappraisal in the era of radical surgery","volume":"8","author":"Eoh KJ","year":"2017","unstructured":"Eoh KJ, Lee JY, Yoon JW, Nam EJ, Kim S, Kim SW, Kim YT. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: reappraisal in the era of radical surgery. Oncotarget. 2017, 8:37807-16. 10.18632\/oncotarget.13696","journal-title":"Oncotarget"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.22514\/ejgo.2022.009","article-title":"Management of nodal disease in advanced-stage ovarian cancer: porta hepatis, celiac, pelvic and paraaortic lymphadenectomy","volume":"43","author":"Taskiran C","year":"2022","unstructured":"Taskiran C, Giray B, Vatansever D, Bilge O. Management of nodal disease in advanced-stage ovarian cancer: porta hepatis, celiac, pelvic and paraaortic lymphadenectomy. Eur J Gynaecol Oncol. 2022, 43:36-45. 10.22514\/ejgo.2022.009","journal-title":"Eur J Gynaecol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji102","article-title":"Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial","volume":"97","author":"Panici PB","year":"2005","unstructured":"Panici PB, Maggioni A, Hacker N, et al.. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005, 97:560-6. 10.1093\/jnci\/dji102","journal-title":"J Natl Cancer Inst"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603323","article-title":"Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis","volume":"95","author":"Maggioni A","year":"2006","unstructured":"Maggioni A, Benedetti Panici P, Dell'Anna T, et al.. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006, 95:699-704. 10.1038\/sj.bjc.6603323","journal-title":"Br J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1995.1061","article-title":"Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy","volume":"56","author":"Spirtos NM","year":"1995","unstructured":"Spirtos NM, Gross GM, Freddo JL, Ballon SC. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Gynecol Oncol. 1995, 56:345-52. 10.1006\/gyno.1995.1061","journal-title":"Gynecol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.3617","article-title":"Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials","volume":"28","author":"du Bois A","year":"2010","unstructured":"du Bois A, Reuss A, Harter P, Pujade-Lauraine E, Ray-Coquard I, Pfisterer J. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials. J Clin Oncol. 2010, 28:1733-9. 10.1200\/JCO.2009.25.3617","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.05.014","article-title":"Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer","volume":"126","author":"Chang SJ","year":"2012","unstructured":"Chang SJ, Bristow RE, Ryu HS. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer. Gynecol Oncol. 2012, 126:381-6. 10.1016\/j.ygyno.2012.05.014","journal-title":"Gynecol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter P","year":"2019","unstructured":"Harter P, Sehouli J, Lorusso D, et al.. A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med. 2019, 380:822-32. 10.1056\/NEJMoa1808424","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3552(89)80051-3","article-title":"16 The effect of chemotherapy on lymph node metastases in ovarian cancer","volume":"3","author":"Burghardt E","year":"1989","unstructured":"Burghardt E, Winter R. 16 The effect of chemotherapy on lymph node metastases in ovarian cancer. Baillieres Clin Obstet Gynaecol. 1989, 3:167-71. 10.1016\/S0950-3552(89)80051-3","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jog.15900","article-title":"Real-world study of lymphadenectomy in patients with advanced epithelial ovarian cancer","volume":"50","author":"Yin Z","year":"2024","unstructured":"Yin Z, Wang M. Real-world study of lymphadenectomy in patients with advanced epithelial ovarian cancer. J Obstet Gynaecol Res. 2024, 50:663-70. 10.1111\/jog.15900","journal-title":"J Obstet Gynaecol Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00036","article-title":"Growth and immune evasion of lymph node metastasis","volume":"8","author":"Jones D","year":"2018","unstructured":"Jones D, Pereira ER, Padera TP. Growth and immune evasion of lymph node metastasis. Front Oncol. 2018, 8:36. 10.3389\/fonc.2018.00036","journal-title":"Front Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363616-evaluating-the-impact-of-retroperitoneal-lymphadenectomy-in-terms-of-morbidity-and-survival-in-advanced-epithelial-ovarian-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:49:50Z","timestamp":1758440990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363616-evaluating-the-impact-of-retroperitoneal-lymphadenectomy-in-terms-of-morbidity-and-survival-in-advanced-epithelial-ovarian-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,21]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.92819","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,21]]}}}